Results obtained from cell culture studies and experimental mouse models indicated that the pharmacological inhibitor, L6H21, was as effective in anti-cancer activity as blockade using MD2 knockout, MD2 knockdown with siRNA, or treatment with MD2 neutralizing antibody. The gene discussed is LY96; the disease is cancer.